# Marimed Inc. (MRMD)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/marimed-inc/ JSON: https://steadybase.io/company/marimed-inc.json Checked Nov 10, 2026. Latest filing read: Aug 13, 2026.

## Company

- Legal name: MARIMED INC.
- Ticker: MRMD (OTC)
- SEC CIK: 0001522767
- Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
- Headquarters: Norwood, MA
- Fiscal year ends: December 31
- SEC filer category: <br>Emerging growth company
- Website: marimedinc.com
- Investor relations: https://ir.marimedinc.com
- LinkedIn: https://www.linkedin.com/company/marimed-inc
- Next earnings date: Nov 12, 2026

## Key facts

- Revenue: $159.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/0001522767-26-000030-index.html
- Operating income: -$2.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/0001522767-26-000030-index.html
- Net income: -$14.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/0001522767-26-000030-index.html
- SG&A: $26.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/0001522767-26-000030-index.html
- Employees: 923 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/mrmd-20251231.htm
- Shares outstanding: 403,040,674 as of Aug 10, 2026 (10-Q filed Aug 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000167/0001522767-26-000167-index.html
- Auditor: M&K Cpas, Pllc, The Woodlands, TX, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/mrmd-20251231.htm

## Business

We are a multi-state cannabis operator (“MSO”) in the United States, headquartered in Norwood, Massachusetts, dedicated to improving lives every day through our high-quality products, our actions, and our values. We develop, own, and manage seed to sale state-licensed, state-of-the-art, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. We have created and continue to develop our own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products utilizing our proprietary strains and formulations.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/mrmd-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $159.8M | -$2.8M | -$14.5M | $26.1M |
| Dec 31, 2024 | $157.7M | $2.6M | -$12.5M | $25.6M |
| Dec 31, 2023 | $148.6M | $14.4M | -$16.0M | $22.1M |
| Dec 31, 2022 | $134.0M | $20.4M | $13.5M | $20.7M |
| Dec 31, 2021 | $121.5M | $26.9M | $7.2M | $27.6M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/marimed-inc.json

## Officers and directors

- Jon R. Levine, President and CEO. LinkedIn: https://linkedin.com/in/jon-levine-85550a9. Source: Form 4 filed Jul 17, 2026, https://www.sec.gov/Archives/edgar/data/1522767/000152276726000159/0001522767-26-000159-index.htm
- Mario Pinho, Chief Financial Officer. Source: Form 4 filed Jul 17, 2026, https://www.sec.gov/Archives/edgar/data/1522767/000152276726000156/0001522767-26-000156-index.htm
- Timothy Shaw, Chief Operating Officer. Source: Form 4 filed Sep 1, 2026, https://www.sec.gov/Archives/edgar/data/1522767/000152276726000170/0001522767-26-000170-index.htm
- Ryan Crandall, Chief Commercial Officer. LinkedIn: https://linkedin.com/in/ryan-crandall-43133b12. Source: Form 4 filed Sep 28, 2026, https://www.sec.gov/Archives/edgar/data/1522767/000152276726000191/0001522767-26-000191-index.htm

## Recent 8-K events

- Oct 29, 2026: Item 5.07, Submission of matters to a vote of security holders; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000213/mrmd-20261028.htm
- Sep 23, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000188/mrmd-20260923.htm
- Aug 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/mrmd-20260812.htm
- Jun 8, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000107/mrmd-20260604.htm
- May 13, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000070/mrmd-20260513.htm
- Mar 11, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000027/mrmd-20260311.htm
- Mar 2, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 3.02, Unregistered sales of equity securities; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/mrmd-20260224.htm
- Nov 5, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000222/mrmd-20251105.htm
- Aug 6, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000167/mrmd-20250806.htm
- Jun 13, 2025: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000130/mrmd-20250612.htm

## Insider trades (Form 4)

- May 22, 2026: Jon R. Levine (President and CEO) bought 60,000 shares, about $4,600. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000080/0001522767-26-000080-index.htm
- May 20, 2026: Jon R. Levine (President and CEO) bought 40,000 shares, about $3,200. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000077/0001522767-26-000077-index.htm
- Dec 12, 2025: Timothy Shaw (Chief Operating Officer) bought 45,455 shares, about $5,000. Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276725000260/0001522767-25-000260-index.htm

## What management said

- "The second quarter represented meaningful progress for MariMed. Revenue increased in both our wholesale and retail businesses sequentially and year over year, resulting in the highest quarterly revenue in our history. These results also reflect a substantial increase in sequential adjusted EBITDA and another quarter in which we generated positive cash flow from operations" Jon Levine, MariMed's Chief Executive Officer (8-K filed Aug 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/ex9918-kearningsq22026.htm

## Latest filings

- 8-K filed Oct 29, 2026: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000213/mrmd-20261028.htm
- 10-K filed Mar 12, 2026: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000030/mrmd-20251231.htm
- 10-Q filed Aug 13, 2026: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000167/mrmd-20260630.htm
- DEF 14A filed Sep 22, 2026: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000183/proxydefinitivedocument202.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/